Drugging the undruggable

被引：3
|
作者：
Mayer, JR [1 ]
DiMarchi, RD
机构：
[1] Lilly Corp Ctr, Lilly Res Labs, Indianapolis, IN 46285 USA
[2] Indiana Univ, Dept Chem, Bloomington, IN 47405 USA
来源：
CHEMISTRY & BIOLOGY | 2005年 / 12卷 / 08期
关键词：
D O I：
10.1016/j.chembiol.2005.08.004
中图分类号：
Q5 [生物化学]; Q7 [分子生物学];
学科分类号：
071010 ; 081704 ;
摘要：
In this issue of Chemistry & Biology, Li and Lawrence [1] report an iterative synthesis/selection process to identify chemically modified peptide ligands possessing high affinity and selectivity for the SH3 domain of Fyn, a member of the Src kinase family.
引用
收藏
页码：860 / 861
页数：2
相关论文
共 50 条
  • [41] Drugging the Undruggable: Small-Molecule Inhibition of the Ras Oncoprotein
    Maurer, T.
    Garrenton, L.
    Oh, A.
    Pitts, K.
    Skelton, N.
    Fauber, B.
    Pan, B.
    Malek, S.
    Stokoe, D.
    Bowman, K.
    Wu, J.
    Giannetti, A.
    Starovasnik, M.
    Mellman, I.
    Jackson, P.
    Rudolph, J.
    Wang, W.
    Fang, G.
    MOLECULAR BIOLOGY OF THE CELL, 2011, 22
  • [42] Drugging "undruggable" genes for cancer treatment: Are we making progress?
    Duffy, Michael J.
    Crown, John
    INTERNATIONAL JOURNAL OF CANCER, 2021, 148 (01) : 8 - 17
  • [43] Drugging the Undruggable: Therapeutic Potential of Targeting Protein Tyrosine Phosphatases
    Zhang, Zhong-Yin
    ACCOUNTS OF CHEMICAL RESEARCH, 2017, 50 (01) : 122 - 129
  • [44] Drugging the undruggable: Lessons learned from protein phosphatase 2A
    Taylor, Derek
    Narla, Goutham
    CANCER RESEARCH, 2020, 80 (16)
  • [45] Drugging the "undruggable" DNA-binding domain of STAT3
    Zhang, Jian-Ting
    Liu, Jing-Yuan
    ONCOTARGET, 2016, 7 (41) : 66324 - 66325
  • [46] PGE2 receptors in detrusor muscle: Drugging the undruggable for urgency
    Hou, Ruida
    Yu, Ying
    Jiang, Jianxiong
    BIOCHEMICAL PHARMACOLOGY, 2021, 184
  • [47] Kronos Bio: Taking a new approach to drugging traditionally undruggable proteins
    2018, American Chemical Society (96):
  • [48] Antibody-siRNA conjugates: drugging the undruggable for anti-leukemic therapy
    Tushir-Singh, Jogender
    EXPERT OPINION ON BIOLOGICAL THERAPY, 2017, 17 (03) : 325 - 338
  • [49] Drugging the undruggable with MCR scaffold manifold: The design and synthesis of covalent inhibitors and macrocycles
    Zarganes-Tzitzikas, Tryfon
    Patil, Pravin
    Doemling, Alexander
    Neochoritis, Konstantinos
    ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY, 2017, 253
  • [50] Drugging the undruggable: a computational chemist's view of KRASG12C
    Bodnarchuk, Michael S.
    Cassar, Doyle J.
    Kettle, Jason G.
    Robb, Graeme
    Ward, Richard A.
    RSC MEDICINAL CHEMISTRY, 2021, 12 (04): : 609 - 614
12345